Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Immunoglobulin Light-chain Amyloidosis 6Vomiting 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Nausea 5Leukemia, Myeloid, Acute 5Leukemia 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma 4Hodgkin Disease 4Breast Neoplasms 4Blast Crisis 4Smoldering Multiple Myeloma 3Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Brain Neoplasms 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Lymphoma, Follicular 2

Interventions

Dexamethasone 16Calcium Dobesilate 9Melphalan 6Lenalidomide 6Cyclophosphamide 5Bortezomib 5pomalidomide 3venetoclax 2daratumumab 2Thalidomide 2Doxycycline 2Biopsy 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2selinexor 1pegfilgrastim 1ixazomib 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1belantamab mafodotin 1auricularum 1Vinorelbine 1Technetium Tc 99m Pyrophosphate 1Technetium 1Tacrolimus 1Surveys and Questionnaires 1Interleukin-2 1In Situ Hybridization, Fluorescence 1In Situ Hybridization 1Hyaluronoglucosaminidase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Amyloidosis × dexamethasone acetate × Clear all
NCT01864018 2025-07-24

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

Mayo Clinic

Phase 1/2 Completed
87 enrolled 13 charts
Plasma cell

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡